The RCT BioVentures program is the vehicle through which Research Corporation Technologies invests in start-up or early-stage companies with technologies that promise patented biomedical products with a clear competitive advantage.
| Company | Date | Round | Size | Participants |
| Catalyst Biosciences | 2/06 | Series B | $30M | 6 |
